Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality
出版年份 2016 全文链接
标题
Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 11, Pages 3008-3019
出版商
Oxford University Press (OUP)
发表日期
2016-08-06
DOI
10.1093/jac/dkw298
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
- (2015) Seyedmojtaba Seyedmousavi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Amphotericin B Deoxycholate, Amphotericin B Lipid Complex, and Liposomal Amphotericin B against Aspergillus fumigatus
- (2015) Zaid Al-Nakeeb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Isavuconazole in a DynamicIn VitroModel of Invasive Pulmonary Aspergillosis
- (2015) Helen Box et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits
- (2015) Ruta Petraitiene et al. CLINICAL INFECTIOUS DISEASES
- Tissue Penetration of Antifungal Agents
- (2014) T. Felton et al. CLINICAL MICROBIOLOGY REVIEWS
- Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
- (2014) J. Livermore et al. mBio
- Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy andIn VitroSusceptibility Breakpoints
- (2013) Ajay Sudan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole (BAL4815) Pharmacodynamic Target Determination in anIn VivoMurine Model of Invasive Pulmonary Aspergillosis against Wild-Type andcyp51Mutant Isolates of Aspergillus fumigatus
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on Voriconazole and Aspergillus spp.
- (2013) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
- (2013) Jodi Lestner et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients
- (2013) Lucy O'Connor et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection
- (2012) J. L. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interaction of Voriconazole and Anidulafungin against Triazole-Resistant Aspergillus fumigatus
- (2012) S. Seyedmousavi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Pharmacodynamic Target Determination against Wild-Type andCyp51Mutant Isolates of Aspergillus fumigatus in anIn VivoModel of Invasive Pulmonary Aspergillosis
- (2012) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Anidulafungin against Clinical Aspergillus fumigatus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis
- (2012) Seyedmojtaba Seyedmousavi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacodynamics of Voriconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis: Implications for In Vitro Susceptibility Breakpoints
- (2012) Adam R. Jeans et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a NewIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Joseph Meletiadis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
- (2011) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
- (2011) J. L. Slater et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts
- (2011) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anidulafungin for Neonatal Hematogenous Candida Meningoencephalitis: Identification of Candidate Regimens for Humans Using a Translational Pharmacological Approach
- (2011) Peter A. Warn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy
- (2011) Susan J. Howard et al. JOURNAL OF INFECTIOUS DISEASES
- The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1->3)- -D-Glucan, and Consequences of Delayed Antifungal Therapy
- (2010) W. W. Hope et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapy for fungal diseases: opportunities and priorities
- (2010) David W. Denning et al. TRENDS IN MICROBIOLOGY
- Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
- (2009) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside
- (2009) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model
- (2008) D. R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- (1→3)-β-D-Glucan in Cereobrospinal Fluid is a Surrogate Marker for Detection and Therapeutic Response of Hematogenous Candida Meningoencephalitis
- (2008) Ruta Petraitiene et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates
- (2007) William W. Hope et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started